There were 83 MACE among 3,570 patients with IMIDs and type 2 diabetes initiating a GLP-1-RA (21.5 per 1,000 person-years) compared to 632 MACE among 7,285 patients initiating a DPP-4i (32.0 per 1,000 person-years). Here, GLP1R is linked to rheumatoid arthritis.